To explore the clinical efficacy of He's Santong acupuncture method in the treatment of tinnitus with hearing loss.

The 100 patients who were brought to our hospital between March 2023 and March 2025 with tinnitus and hearing loss were split into two groups at random: the control group (50 cases, 1 case excluded) and the intervention group (50 cases, 1 case excluded). The control group was treated with routine acupuncture and moxibustion, and the intervention group was treated with He's santong acupuncture method. Both groups were treated for 3 weeks. The clinical efficacy, tinnitus evaluation questionnaire (TEQ) score, tinnitus handicap inventory (THI) score, tinnitus visual analogue scale (VAS) score, average threshold of air permeability hearing, pittsburgh sleep quality index (PSQI) score, hospital anxiety and depression scale (HADS) score, and adverse reactions were compared between the two groups.

Following treatment, the control group's overall effective rate was 67.35% (33/49) and the intervention group's was 87.76% (43/49). The intervention group outperformed the control group in terms of overall effectiveness (P < 0.05). Treatment resulted in decreased scores for TEQ, THI, VAS, PSQI, HADS, and average threshold of air permeability hearing in both groups (P < 0.05), with the intervention group outperforming the control group (P < 0.05).

He's Santong method of acupuncture has a significant clinical effect in the treatment of tinnitus with hearing loss. It can significantly improve the patient's tinnitus symptoms, hearing level, sleep quality and anxiety and depression, and has high safety. It is suitable for application and promotion in clinical practice.

To evaluate the clinical efficacy of acupuncture combined with electroacupuncture in the treatment of early to mid-stage osteoarthritis of the knee based on the theory of 'Shaoyang Governing the Bone'.

A total of 102 patients with early to mid-stage knee osteoarthritis (KOA) admitted to Sichuan Orthopedic Hospital from August 2022 to August 2024 were enrolled and randomly assigned to the observation group (n = 50) or the control group (n = 52). All patients received basic treatment and specific exercise training. In the control group, early-stage patients were treated with meloxicam tablets and glucosamine hydrochloride capsules, while mid-stage patients additionally received intra-articular sodium hyaluronate injection. On the basis of the control regimen, patients in the observation group underwent acupuncture treatment guided by the "Shaoyang governing bone" theory combined with electroacupuncture using a sparse-dense wave. Both groups were treated for three courses, with each course lasting two weeks. Observe the changes of clinical efficacy, SF-36 health survey scale score, TCM symptom score, WOMAC and VAS scale score, β-collagen degradation product (β-CTX) and 25 hydroxyvitamin D (25-OH-D) level in the two groups.

After three courses of treatment, the total efficacy rate of 98. 00% in the observation group was significantly higher than that of 84.62% in the control group (P <0.05), the scores of the eight dimensions of SF-36 scale were significantly improved (P <0.05), the TCM symptom scores, the scores of WOMAC and VAS scales were significantly reduced (P <0.05), the level of β-CTX was significantly reduced (P <0.05) and 25-OH-VD levels were significantly higher (P <0.05), and the improvement of all indicators was more obvious in the observation group (P < 0.05). In addition, there were 3 cases of adverse reactions in the observation group and 4 cases in the control group, indicating that this study has a better safety profile.

Based on the theory that "Shaoyang governing the bones," the therapeutic approach combining the method of regulating qi, activating blood circulation, and tonifying the kidney with electroacupuncture has shown good clinical efficacy in the treatment of early- and middle-stage knee osteoarthritis. It can significantly improve patients' quality of life, relieve pain, regulate bone metabolism to reduce bone loss, slow down joint degeneration, enhance bone health, and thereby improve knee joint function.

To investigate the efficacy and safety of Shiwei Shengxue Decoction in improving the nutritional status of patients with advanced non-small cell lung cancer (NSCLC) cachexia (Qi and Blood Deficiency Syndrome).

A prospective cohort study design was adopted. Patients with advanced NSCLC who met the diagnostic criteria for Qi and Blood Deficiency Syndrome and cancer cachexia, admitted to Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, and Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, from March 2023 to March 2024, were enrolled. Based on whether they received Shiwei Shengxue Decoction (treatment for≥4 weeks), patients were naturally assigned to an exposed group and a non-exposed group. Both groups received conventional nutritional treatment.

After propensity score matching (PSM), 45 pairs of patients were included. The total effective rate for improving nutritional status in the exposed group was 77.8% (35/42), which was significantly higher than that in the non-exposed group (48.9%, 22/45), with a statistically significant difference (P < 0. 05). The exposed group showed superior improvements in increasing food intake, maintaining body weight, enhancing grip strength, and raising serum hemoglobin (Hgb) levels compared to the non-exposed group (P <0.05). However, no statistically significant differences were observed in KPS scores or serum albumin (ALB) levels between the two groups (P > 0.05). No adverse events were reported during the study period.

Shiwei Shengxue Decoction can effectively improve the nutritional status of patients with advanced NSCLC cachexia (Qi and Blood Deficiency Syndrome) with a favorable safety profile.

To explore the clinical efficacy of Banxia Baizhu Tianma Decoction on patients with phlegm turbidity obstruction type of otolithiasis in recovery phase.

A total of 135 patients with otolithiasis of phlegm turbidity obstruction type were selected and classified into control group (otolith manipulative reduction treatment, 68 cases) and treatment group (otolith manipulative reduction treatment plus Banxia Baizhu Tianma Decoction, 67 cases) by random number table method. The number of cumulative occurrences, duration, treatment effective rate, TCM syndromes scores, dizziness handicap inventory (DHI), Hamilton anxiety scale (HAMA) and treatment safety were compared between groups of patients.

The number of cumulative occurrences and duration in the control group were (3.18 ± 0.59) times and (30.51 ± 5.16) d and those in the treatment group were (2.59 ± 0.61) times and (25.69 ± 5.39) d, and the two indexes in the control group were higher than those in the treatment group (t=5.712, 5.308, < 0.001) . The effective rate of treatment in the treatment group with 95. 52% (64/67) was higher than 82.35% (56/68) in the control group (P <0. 05). After treatment, the scores of various TCM syndromes were lower in the treatment group than those in the control group (P <0.05). The scores of items of DHI in the treatment group after treatment were lower than those in the control group (P <0.05). After treatment, the treatment group had lower HAMA scores than the control group (P <0.05). No statistical difference was exhibited in the safety between both groups (P >0.05).

Banxia Baizhu Tianma Decoction for phlegm turbidity obstruction type of otolithiasis in recovery phase can effectively reduce the number and time of recurrence, enhance the effective rate of treatment, improve the symptoms, relieve the vertigo degree, and alleviate the anxiety of patients, and it will not increase the risk of treatment.

To analyze the therapeutic effect of Xuefu Zhuyu decoction combined with video-assisted thoracoscopic minimally invasive surgery in patients with traumatic hemopneumothorax (TH) of qi stagnation and blood stasis type.

A total of 97 patients with qi stagnation and blood stasis type TH admitted to Haian Hospital of Traditional Chinese Medicine from May 2021 to September 2024 were selected and randomly divided into two groups. Both groups were given thoracoscopic minimally invasive surgery. 48 cases in the control group received conventional treatment after the operation, and 49 cases in the observation group were treated with Xuefu Zhuyu decoction in addition after the operation. The therapeutic effects of the two groups were compared.

The effective rate of treatment in the observation group was higher than that in the control group (P < 0. 05). After 7 days of treatment, the TCM syndrome score, pulmonary function indicators and coagulation indicators of the observation group were better than those of the control group (P < 0. 05). After 7 days of treatment, the observation group had significantly lower VAS scores than the control group (P <0.05). The time of the first expectoration in the observation group was lower than that in the control group, and the sputum output was higher than that in the control group (P <0.05). Comparison of the incidence of complications between the two groups (P > 0.05).

The treatment of TH patients with Xuefu Zhuyu decoction combined with thoracoscopic minimally invasive surgery has a significant effect. It can reduce the TCM syndrome score, alleviate the degree of pain, shorten the expectoration time, and improve coagulation indicators and lung function indicators.

Based on the theory of" Kidney Governing Reproduction", the clinical efficacy of Yushen Zhuyun Formula in treating ovulation dysfunction infertility was discussed.

A total of 102 patients with ovulatory infertility admitted to Nanyang Second General Hospital from January 2022 to January 2024 were selected and randomly divided into a control group (conventional western medicine treatment) and a study group (conventional western medicine + treatment of Yushen Zhuyun Formula) with 51 cases in each group. Record and compare the clinical curative effect of TCM syndrome integral, the two groups, ultrasonic index, sex hormone [serum luteinizing hormone (LH), estradiol (E₂), follicle-stimulating hormone (FSH)] level and incidence of adverse reactions.

After treatment, two groups of TCM syndrome integral are lower than before the treatment, and the team was lower (P <0.05). After treatment, clinical treatment group total effective rate was 92.16%, 76.47% higher than the control group (P <0.05). After treatment, the number of dominant follicles was more in both groups than before treatment, and more in the study group (P <0. 05). Two groups of dominant follicle diameter and the thickness of endometrium is higher than before the treatment, and the group is higher (P < 0.05). After treatment, two groups of LH, FSH level was reduced, the E₂ levels are higher, and larger variations in team (P < 0.05). During the treatment period, the incidence of adverse reactions in the study group was 5.82%, which was lower than that in the control group 15. 69% (P > 0.05). The natural pregnancy rate in the study group was 41.18%, which was higher than the 21.57% in the control group (P < 0.05).

The Yushen Zhuyun Formula, based on the theory of "Kidney Governing Reproduction", has significant effect on ovulation dysfunction infertility patients, can effectively promote follicle and endometrial development, regulate the recovery of sex hormone levels, with a low incidence of adverse reactions.

To analyze the therapeutic effect of Yupingfeng Powder combined with modified Baohe Pill in the treatment of allergic rhinitis (AR) of spleen deficiency and dampness excess type in children.

A total of 92 children with AR admitted to Tai'an Maternal and Child Health Hospital from February 2024 to November 2024 were selected and divided into a control group and an observation group according to different treatment methods. There were 45 cases in the control group treated with conventional intervention, and 47 cases in the observation group additionally treated with Yupingfeng Powder combined with modified Baohe Pill. Both groups received 14 days of treatment. The therapeutic effects of the two groups were compared; the levels of interleukin (IL-1β, IL-6), procalcitonin (PCT), and immunoglobulin (IgE, IgG) were compared between the two groups; the TCM syndrome scores, nasal airway resistance (NAR), nasal cavity volume at 0~5 cm (NCV), minimal nasal cross-sectional area (NMCA), and nasal respiratory volume within 20 seconds (NS) were observed in both groups; the occurrence of adverse reactions in the two groups was also recorded.

The therapeutic effect of the observation group was superior to that of the control group (P < 0.05). After 14 days of treatment, the levels of interleukin (IL-1β, IL-6), procalcitonin (PCT), immunoglobulin (IgE, IgG), and TCM syndrome scores in the observation group were significantly lower than those in the control group (P <0.01). After 14 days of treatment, the NAR level in the observation group was lower than that in the control group (P <0.01), while the NCV, NMCA and NS levels were higher than those in the control group (P <0. 01). No severe adverse reactions occurred in either group during the treatment period.

Yupingfeng Powder combined with modified Baohe Pill exerts a significant therapeutic effect in children with AR. It can reduce TCM syndrome scores and inflammatory levels, improve nasal ventilation function, enhance immune status, and has acceptable safety in clinical application.

To investigate the impact of traditional Chinese medicine (TCM) comprehensive therapy, grounded in the theoretical framework of lung, spleen, and kidney treatment, on the balance of Th1/Th2 cytokines and airway remodeling in patients with stable chronic obstructive pulmonary disease (COPD).

A total of 180 patients with stable COPD who attended the hospital between March 2023 and December 2024 were selected as study participants. A total of 180 patients with stable chronic obstructive pulmonary disease (COPD) who were treated at our hospital between January 2022 and September 2023 were recruited as research participants. These patients were allocated into four groups: the Traditional Chinese Medicine (TCM) group (n = 60), which received basic Western medicine treatment combined with a TCM formula for replenishing qi, dredging collaterals, strengthening the spleen, and tonifying the kidney; the Acupoint group (n = 60), which received basic Western medicine treatment combined with acupoint application therapy; the Combined group (n = 60), which received basic Western medicine treatment combined with both the TCM formula and acupoint application therapy. Data collection included pulmonary function indices [forced vital capacity (FVC), forced expiratory volume in the first second (FEV1)], COPD Assessment Test (CAT) scores, modified British Medical Research Council dyspnea questionnaire (mMRC) scores, serum interferon-γ (IFN-γ), and interleukin-4 (IL-4) levels. Additionally, the study evaluated the ratio of airway wall thickness to external diameter (T/D), the percentage of airway wall thickness relative to total airway diameter (WA%), airway smooth muscle area (ASM%), emphysema index (LAA%), and the incidence of adverse reactions.

The total efficacy rate in the combined treatment group was 100.00% (60/60), which was significantly higher than that in the TCM group (86.67%, 52/60) and the acupoint therapy group (88.33%, 53/60) (86.67%) and the acupoint therapy group (88.33%) (P < 0.05). No significant difference was observed in the total clinical effective rate between the Chinese Medicine group and the Acupoint Therapy group (P > 0.05). After 9 months of treatment, there were no significant differences in serum IFN-γ, IL-4 levels or the IFN-γ/IL-4 ratio between the Chinese medicine group and the acupoint therapy group (P >0.05). At the 9-month mark, serum IFN-γ levels and the IFN-γ/IL-4 ratio in the Combined Therapy group were significantly higher than those in both the Chinese Medicine group and the Acupoint Therapy group (P < 0.05). At the 9-month mark, serum IL-4 levels in the Combined Therapy group were significantly lower than those in both the Chinese Medicine group and the Acupoint Therapy group (P < 0.05). At 3, 6, and 9 months of treatment, the T/D, WA, ASM, and LAA values in the combined treatment group were significantly lower than those in the Chinese medicine group and the acupoint therapy group (P <0.05). At 3, 6, and 9 months of treatment, there were no significant differences in T/D, WA, ASM, or LAA values between the Chinese medicine group and the acupoint therapy group (P >0.05). No significant difference in clinical efficacy was observed between the TCM group and the acupoint therapy group (P >0.05). Post-treatment analysis revealed no significant differences in serum IFN-γ and IL-4 levels, the IFN-γ/IL-4 ratio, as well as T/D, WA, ASM, and LAA values between the TCM group and the acupoint therapy group (P > 0.05). In contrast, the combined treatment group exhibited significantly higher post-treatment serum IFN-γ levels and IFN-γ/IL-4 ratios compared to both the TCM and acupoint therapy groups (P <0.05). Additionally, the combined treatment group demonstrated significantly lower post-treatment serum IL-4 levels and T/D, WA, ASM, and LAA values compared to the TCM and acupoint therapy groups (P < 0.05). The incidence of adverse reactions in the three groups was 15.00%, 16.67%, and 5.00%, respectively, with no statistically significant differences observed among the groups (P > 0.05).

Traditional Chinese medicine comprehensive therapy, grounded in the theoretical framework of lung, spleen, and kidney treatment, can regulate the Th1/Th2 immune balance via multiple targets and inhibit airway remodeling. This approach effectively enhances lung function and alleviates clinical symptoms in patients with stable COPD. It demonstrates significant advantages in terms of efficacy stability and safety, thereby exhibiting high application value.

To perform modified Shengma Biejia Decoction combined with Tiaoshen acupuncture therapy for patients with herpes zoster (HZ), and analyze the influence on pain and inflammatory factors.

According to the random number table method, 98 patients with HZ admitted to the hospital from January 2022 to January 2025 were divided into control group (n = 49, Tiaoshen acupuncture method) and combined group (n = 49, modified Shengma Biejia Decoction combined with Tiaoshen acupuncture therapy). The clinical efficacy, pain status [visual analogue scale (VAS)], serum pain mediators [neurotensin (NT), β-endorphin (β-EP), substance P (SP)], serum inflammatory factors [interleukin-2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)] and occurrence of adverse reactions were compared between groups of patients.

Compared with the control group, the combined group had higher total effective rate of treatment (P <0.05). The VAS scores in the combined group after 7 days and 14 days of treatment were lower (P < 0.05), and the levels of serum NT and β-EP were higher (P <0.05) while the level of serum SP was lower (P < 0.05). The combined group had higher IL-2 (P < 0.05), lower levels of IL-6 and TNF-α (P <0.05) and lower total incidence rate of adverse reactions (P < 0.05).

The combination of modified Shengma Biejia Decoction and Tiaoshen acupuncture therapy is effective in the treatment of HZ, and it can effectively relieve the pain, and regulate the levels of pain-related mediators and inflammatory factors, with few adverse reactions.

To investigate the clinical efficacy of modified Baihu Guizhi Decoction combined with methotrexate (MTX) in the treatment of rheumatoid arthritis (RA)

A randomized controlled trial was conducted. A total of 120 RA patients admitted to the outpatient and inpatient departments of Rheumatology and Immunology at Xinyang Central Hospital from January 2022 to April 2024 were randomly divided into a control group and an observation group, with 60 cases in each group. The control group received standard-dose MTX, while the observation group received modified Baihu Guizhi Decoction in addition to the MTX regimen. The treatment duration was 12 weeks. Traditional Chinese medicine (TCM) syndrome scores, Visual Analog Scale (VAS) scores, joint swelling degree, morning stiffness duration, erythrocyte sedimentation rate (ESR), rheumatoid factor (RF) titer, C-reactive protein (CRP), and macrophage migration inhibitory factor (MIF) levels were compared between the two groups before and after treatment to evaluate efficacy and safety.

After treatment, TCM syndrome scores, VAS scores, morning stiffness duration, and joint swelling degree improved in both groups, and ESR, RF, CRP, and MIF levels decreased (P < 0.05). The observation group showed significantly greater improvements compared to the control group (P <0.05). The proportion of patients achieving ACR50/70 improvement criteria was higher (P < 0.05), and the incidence of adverse reactions was lower (P < 0.05) in the observation group.

Modified Baihu Guizhi Decoction combined with MTX demonstrates significant efficacy in treating RA with Wind-Damp-Heat obstruction syndrome. Its mechanism of action may be related to the regulation of CRP and MIF expression.